Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycostatin for Anastomotic Leakage in Esophageal Cancer Surgery
NCT00942526Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nystatin oral suspension in Anastomotic Leak (AL) (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: All Cause Anastomotic Leakage at 2 years. Status: unknown.
02
Drugs
nystatin oral suspension
03
Conditions
Anastomotic Leak (AL)
Beyond the preview
Go deeper on NCT00942526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942526.